Who should avoid bisphosphonates?
Clinicians should avoid oral bisphosphonates in patients who are at a higher risk of these gastrointestinal adverse effects, including those who are not able to sit upright for at least 30 minutes after taking the bisphosphonate, and patients with esophageal disorders such as achalasia, esophageal stricture, Barrett’s …
Can bisphosphonates cause osteonecrosis?
Recently, however, high-dose intravenous bisphosphonates have been identified as a risk factor for osteonecrosis of the jaw among oncology patients. Low-dose bisphosphonate use in patients with osteoporosis or other metabolic bone disease has not been causally linked to the development of osteonecrosis of the jaw.
What drugs are considered bisphosphonates?
List of Bisphosphonates:
| Drug Name | Avg. Rating | Reviews |
|---|---|---|
| Fosamax (Pro) Generic name: alendronate | 3.1 | 54 reviews |
| Zometa (Pro) Generic name: zoledronic acid | 4.8 | 37 reviews |
| Actonel (Pro) Generic name: risedronate | 3.3 | 25 reviews |
| Aclasta Generic name: zoledronic acid | 4.2 | 20 reviews |
Which bisphosphonate is best for hip?
Regarding hip fractures, there is a 47% probability that zoledronic acid shows the greatest risk reduction, followed by alendronate (36%) and risedronate (11%).
What are the two medications that may cause osteoporosis after long term use?
The medications most commonly associated with osteoporosis include phenytoin, phenobarbital, carbamazepine, and primidone. These antiepileptic drugs (AEDs) are all potent inducers of CYP-450 isoenzymes.
What are the two main adverse effects of bisphosphonates?
General side effects of bisphosphonates and denosumab
- Fever and flu-like symptoms.
- Low levels of calcium in your blood (hypocalcaemia)
- Bone and joint pain.
- Changes in bowel movements.
- Tiredness and low energy levels.
- Feeling sick.
- Changes to your kidneys.
- Irritation of the food pipe (oesophagus)
What are the signs of bisphosphonate associated osteonecrosis?
In patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ), panoramic and plain radiography of the mandible reveal areas of sclerosis, destruction, sequestration, or pathologic fractures. Delayed or persistent tooth sockets after extraction may also be revealed in these patients.
What is osteonecrosis of the hip?
Osteonecrosis of the hip is a painful condition that occurs when the blood supply to the head of the femur (thighbone) is disrupted. Because bone cells need a steady supply of blood to stay healthy, osteonecrosis can ultimately lead to destruction of the hip joint and severe arthritis.
What medication causes osteonecrosis?
Bisphosphonates — such as alendronate (Fosamax, Binosto), risedronate (Actonel, Atelvia), ibandronate (Boniva) and zoledronic acid (Reclast, Zometa) — and denosumab (Prolia, Xgeva) have been linked to osteonecrosis of the jaw and atypical femoral fractures.
What is the safest bisphosphonate?
64–66,71,72 Recent publications indicate that the use of oral bisphosphonates (alendronate and risedronate) may be safe and effective in patients with glomerular filtration rates less than 30 mL/min.
Is Prolia better than bisphosphonates?
When it comes to improving bone density and reducing fracture risk, denosumab may provide better results than do bisphosphonates. As with bisphosphonates, it has a small risk of serious side effects, such as skin infections, headache and fatigue.
What is the new drug for osteoporosis?
Romosozumab (Evenity). This is the newest bone-building medication to treat osteoporosis.
Does bisphosphonate treatment for osteoporosis increase the incidence of ONJ fractures?
The current perception among dentists and oral-maxillofacial surgeons seems to be that low-dose bisphosphonate treatment for osteoporosis is linked to an increased incidence of ONJ, while on the other hand endocrinologists may suggest increased prescribing to decrease the incidence of osteoporotic fractures.
What is the MRONJ risk of bisphosphonate therapy?
A final study showed patients receiving long term oral bisphosphonate therapy < 4 years only had a MRONJ risk of 0.1% and over 4 years a MRONJ risk of 0.21%. RANK-L inhibitors injected subcutaneously, for cancer therapy or osteoporosis, showed a risk of developing MRONJ of between 0.7% and 1.9%.
What is the mechanism of action of bisphosphonates on osteoclasts?
4.2. Mechanism of Action During bone resorption, bisphosphonates impair the ability of the osteoclasts to form the ruffled border, to adhere to the bony surface and to produce the protons necessary for continued bone resorption [ 17 – 19 ].
What is bisphosphonates (BP)?
Bisphosphonates (BPs) are antiresorptive drugs that act specifically on osteoclasts, thereby maintaining bone density and strength [2]. The drug is used for many indications including prevention and treatment of primary and secondary osteoporosis, hypercalcaemia, multiple myeloma, and osteolysis due to bone metastases and Paget’s disease [3, 4]
